Sort
39,280 grants matching “leukemia”
Elucidating time-dependent mechanisms of genetic and epigenetic reprogramming in single cancer cells
$357,404Raul Rabadan · Columbia University Health Sciences · U54 · FY2019 · CA
Molecular and cellular mechanisms of the actin cytoskeleton organization and function
$357,389Dmitri Kudryashov · Ohio State University · R01 · FY2025 · GM
Molecular and cellular mechanisms of the actin cytoskeleton organization and function
$357,389Dmitri Kudryashov · Ohio State University · R01 · FY2023 · GM
Molecular and cellular mechanisms of the actin cytoskeleton organization and function
$357,389Dmitri Kudryashov · Ohio State University · R01 · FY2024 · GM
Pleiotrophin, a paracrine regulator of hematopoietic stem cell fate
$357,381John P Chute · University Of California Los Angeles · R01 · FY2017 · HL
Polyploidy, aneuploidy and genome stability
$357,376David S Pellman · Dana-Farber Cancer Inst · R01 · FY2015 · GM
Biochemistry of Apoptosis in CLL
$357,340John C Reed · University Of California, San Diego · P01 · FY2007 · CA
(PQ2) Donor socioeconomic status as a predictor of altered immune function and treatment response following hematopoietic cell transplantation for hematologic malignancy
$357,337Jennifer Mary Knight · Medical College Of Wisconsin · R01 · FY2020 · CA
Lineage decision in blood stem and progenitor cells
$357,337Dana-Farber Cancer Institute · R01 · FY2005 · DK
Lineage decision in blood stem and progenitor cells
$357,337Dana-Farber Cancer Institute · R01 · FY2004 · DK
Targeting AKT signaling in AML
$357,290Marina Y Konopleva · University Of Tx Md Anderson Can Ctr · R21 · FY2011 · CA
Center for Integrative Research on Childhood Leukemia and the Environment
$357,269Catherine Metayer · University Of California Berkeley · P50 · FY2015 · ES
Understanding T Cell Rapamycin Resistance
$357,257Daniel Fowler · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Crosstalk between leukemic blasts and the BM microenvironment contribute to leukemic transformation
$357,254Adrienne M. Dorrance · Ohio State University · R01 · FY2023 · CA
Core D: Biospecimen and Pathology Core
$357,229Andrea Marcogliese Sheehan · Baylor College Of Medicine · P50 · FY2025 · CA
Lymphoid Tissue Inducer/NK22 Cells and Post-transplant Immune Recovery
$357,200Michael R Verneris · University Of Minnesota · R01 · FY2013 · AI
MICRORNA REGULATION OF NK CELL DEVELOPMENT AND FUNCTION
$357,200Todd A Fehniger · Washington University · R01 · FY2013 · AI
GENE REGULATION GOVERNING T LYMPHOCYTE FATE DECISIONS
$357,200Takeshi Egawa · Washington University · R01 · FY2013 · AI
CD19-Specific CB T-cell Therapy for Patients with B-cell Malignancies
$357,151Gianpietro Dotti · University Of Tx Md Anderson Can Ctr · P01 · FY2013 · CA
Human Minor Histocompatibity Antigens
$357,115Jerome Ritz · Dana-Farber Cancer Inst · P01 · FY2009 · CA
Genetic Approaches to Enhance the Anti-Tumor Functions of T Lymphocytes
$357,114Michel Sadelain · Sloan-Kettering Inst Can Research · P01 · FY2007 · CA
Mechanisms of Metabolic Gene Mutations in Cancer
$357,100Yue Xiong · Univ Of North Carolina Chapel Hill · R01 · FY2012 · CA
Immunogenetics of Graft-Versus-Host Disease
$357,094Effie W Petersdorf · Fred Hutchinson Cancer Research Center · P01 · FY2009 · CA
New Triterpenoids for Cancer Chemoprevention and Therapy
$357,075Dartmouth College · R01 · FY2004 · CA
Dartmouth Lead Participation in NCI National Clinical Trials Network
$357,058Konstantin H. Dragnev · Dartmouth College · U10 · FY2017 · CA